The Invisible Hand in Medicine Pricing
When you pay $200 for a medication at the pharmacy, you might wonder: who gets that money? The answer involves a complex web of manufacturers, wholesalers, pharmacy benefit managers (PBMs), insurers, and pharmacies — with PBMs sitting at the center of the entire system.
PBMs are the third-party administrators that manage prescription medicine benefits for insurers, employers, Medicare Part D plans, and Medicaid managed care organizations. They cover approximately 270 million Americans and process over 5 billion prescriptions annually. Yet most patients have never heard of them.
What PBMs Do
PBMs perform several core functions:
1. Formulary Management PBMs develop medicine formularies — the list of covered medicines divided into tiers (typically Tier 1: generics → Tier 4: specialty biologics). Medicine placement on formulary determines patient cost sharing. Getting on formulary (or off it) is worth billions to medicine manufacturers.
2. Negotiating Rebates from Medicine Manufacturers This is the centerpiece of PBM revenue. Manufacturers pay rebates to PBMs in exchange for favorable formulary placement — inclusion on formulary, preferred tier status, exclusion of competitors.
Rebate mechanics:
Example: Medicine list price $5,000/month. PBM negotiates 40% rebate ($2,000). Net cost to payer: $3,000. But if patient's copay is 20% of list price: $1,000/month. Patient pays 33% of what the system actually pays — coinsurance based on inflated list price.
3. Prior Authorization (PA) PBMs require clinical approval before covering certain medicines. PA serves a legitimate cost-management purpose but has grown to create significant treatment delays:
4. Step Therapy ("Fail First") Before covering the physician's prescribed medicine, the plan requires the patient to try and fail on a cheaper alternative first. Often clinically appropriate — sometimes used to delay access to effective medications for conditions where the prescribed medicine is clearly superior.
5. Specialty Pharmacy Carve-Outs PBMs often require specialty medications to be dispensed through their own affiliated specialty pharmacy, limiting patient choice and steering revenue to their own subsidiaries.
The Big 3 PBMs and Their Market Power
Three PBMs control ~80% of all US prescriptions:
The vertical integration — PBM + insurer + pharmacy + hospital — creates potential conflicts of interest: the same entity that determines coverage and cost is also in the business of providing that care and dispensing those medicines.
The FTC launched a major investigation into PBMs in 2022. A preliminary report (2024) found that PBMs use their power to favor affiliated pharmacies and inflate medicine costs.
PBM Reform Efforts
Transparency legislation:
Rebate pass-through: The Inflation Reduction Act (2022) includes PBM reform provisions. The CMS rule on Medicare Part D requires PBMs to pass medicine manufacturer rebates directly to beneficiaries at the pharmacy counter for certain medicines — reducing out-of-pocket costs based on real medicine prices rather than inflated list prices.
340B Program: Hospitals and clinics serving low-income patients can purchase medicines at steep discounts (340B prices); PBMs have increasingly restricted 340B medicine reimbursement at affiliated pharmacies, generating controversy.
What Patients Can Do
1. Ask for generic alternatives — PBMs and formularies generally favor generics; your cost sharing will be lower 2. Appeal prior authorizations — physicians can submit clinical appeals; approval rates on first appeal are often 50%+ 3. Ask about formulary exceptions — if your medication is non-preferred, request a formulary exception showing medical necessity 4. Check GoodRx — GoodRx negotiates its own discounts separate from your PBM; for some generics, GoodRx prices are lower than your insurance copay 5. Compare mail-order vs. retail — your PBM's mail-order pharmacy often has lower cost-sharing for 90-day supplies 6. Patient Assistance Programs — manufacturer PAPs provide free/discounted medicines to qualifying patients, bypassing PBM entirely
Frequently Asked Questions
Why is my medicine cheaper at GoodRx than with my insurance?
GoodRx negotiates separate discount contracts with pharmacies. For some generics, these discounts result in lower prices than your insurance copay (which is based on your plan's tier structure negotiated by your PBM). When GoodRx is cheaper, you pay as a cash customer — your insurance is not billed and it doesn't count toward your deductible.
What can I do if my insurance won't cover my medication?
First, ask your prescriber if there's an alternative on the formulary. If the prescribed medicine is medically necessary, have your prescriber submit a prior authorization or formulary exception with clinical justification. If denied, you have the right to appeal. External/independent review is available if internal appeals fail. Contact your state insurance commissioner if appeals are unreasonably denied.
Why do medicine list prices keep rising even when rebates increase?
The rebate system creates perverse incentives: higher list prices generate larger dollar-value rebates, even at the same percentage. PBMs benefit from higher list prices because their revenue is often tied to rebate spread. This is why list prices rose 40% between 2014 and 2020 even as net prices were more stable. Reform efforts focus on eliminating rebates and replacing with direct price negotiation.
How does Medicare Part D medicine coverage work with PBMs?
Medicare Part D plans are administered by private insurers using PBMs. Each plan has its own formulary and cost-sharing structure. During the coverage gap ('donut hole'), patients historically paid a percentage of list price. The Inflation Reduction Act 2022 capped Medicare Part D out-of-pocket costs at $2,000/year starting 2025 and requires manufacturer discounts in the coverage gap.
Medicines Mentioned in This Article
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making any medication decisions.